Axiora Medical
Axiora Medical
Elbow joint replacement, or total elbow arthroplasty (TEA), has evolved significantly. As a leading exporter from China, Axiora Medical Technology emphasizes biocompatibility and kinematic accuracy. Our engineering roadmap focuses on reducing periprosthetic fractures and improving long-term fixation through advanced metallurgy and coating technologies.
The global orthopedic implant market is shifting toward patient-specific instrumentation (PSI). Chinese manufacturing has transcended simple assembly, moving into high-end CNC precision machining and rigorous 100% finished product inspections. Axiora integrates 15 years of industry expertise to provide solutions that meet strict CE and ISO international standards.
86 Engineers driving innovation with 126 patents and new products launched annually.
100% inspection protocol using CMM, Tensile, and Salt Spray Testing.
Integrated network of 1,120+ partners ensuring rapid OEM/ODM delivery.
| Metric | Axiora Standards |
|---|---|
| Annual Export Revenue | USD 26 Million |
| Manufacturing Area | 18,600 m² |
| Quality Staff | 48 Professionals |
Our focus on reverse engineering and material science, combined with an aseptic production environment, ensures our implants mimic natural joint motion while maintaining longevity.
